7 results match your criteria: "Santa Casa de Curitiba Hospital[Affiliation]"
Int J Dermatol
October 2024
Department of Dermatology, Santa Casa de Curitiba Hospital, Curitiba, Brazil.
Background: Leprosy is a chronic infection with high morbidity in Brazil. Primary care physicians' lack of knowledge about the disease may play a significant role in underdiagnosis. This study aimed to assess primary care physicians' ability to identify typical leprosy skin lesions and their knowledge of the subject.
View Article and Find Full Text PDFArq Bras Cir Dig
September 2020
Department of General and Digestive Surgery, Santa Casa de Curitiba Hospital, Curitiba, PR, Brazil.
J Dermatolog Treat
December 2021
Department of Dermatology, Santa Casa de Curitiba Hospital, Paraná, Brazil.
Introduction: Actinic cheilitis (AC) is part of a spectral disease of keratinocyte carcinomas considered by some authors an early stage of squamous cell carcinoma. Treatment options for AC can be lesion and field-directed therapies. Ingenol mebutate (IM) induces rapid and direct cell death and immune responses being able to destruct dysplastic cells.
View Article and Find Full Text PDFAm J Dermatopathol
November 2019
Department of Dermatology, Federal University of Amazonas, Manaus, AM, Brazil.
J Fungi (Basel)
September 2019
Hospital de Clínicas de Curitiba-Paraná Federal University (UFPR), Department of Public Health, Rua General Carneiro, 181, 80.060-900 Curitiba, Brazil.
Terbinafine has proved to treat numerous fungal infections, including onychomycosis, successfully. Due to its liver metabolization and dependency on the cytochrome P450 enzyme complex, undesirable drug interaction are highly probable. Additionally to drug interactions, the treatment is long, rising the chances of the appearance of side effects and abandonment.
View Article and Find Full Text PDFJ Cosmet Dermatol
December 2019
Dermatology Department, Santa Casa de Curitiba Hospital, Curitiba, Brazil.
Depigmented lesions may occur as postinflammatory sequelae of subacute cutaneous lupus erythematosus (SCLE), leading to great psychosocial impact. A 53-year-old male patient presented with post-SCLE depigmented facial lesions after five years of disease stability. We proposed surgical treatment with melanocyte-keratinocyte transplantation procedure (MKTP), and after five months the patient achieved 90% repigmentation, without Koebner phenomenon (KP).
View Article and Find Full Text PDFAm J Dermatopathol
November 2019
Department of Dermatology, Federal University of Amazonas, Manaus, AM, Brazil.